リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Coexistence of growth hormone, adrenocorticotropic hormone, and testosterone deficiency associated with coronavirus disease 2019: a case followed up for 15 months」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Coexistence of growth hormone, adrenocorticotropic hormone, and testosterone deficiency associated with coronavirus disease 2019: a case followed up for 15 months

Yoshimura, Kai Yamamoto, Masaaki Inoue, Tomoya Fukuoka, Hidenori Iida, Keiji Ogawa, Wataru 神戸大学

2022

概要

Coronavirus disease 2019 (COVID-19) is associated with endocrine disorders, but their long-term clinical course remains unclear. We here report the 15-month clinical course for an individual with multiple endocrine disorders of the pituitary gland and testis likely triggered by COVID-19. A 65-year-old man with no history of endocrinopathy was admitted for acute COVID-19 pneumonia. Although his respiratory condition improved after administration of antiviral drugs, his blood pressure dropped suddenly to a preshock level and was refractory to vasopressors. The circulating adrenocorticotropic hormone (ACTH) and cortisol concentrations were low, and secondary adrenal insufficiency was suspected. Administration of hydrocortisone rapidly ameliorated the hypotension, and the patient was discharged taking 15 mg of hydrocortisone daily. An insulin tolerance test performed 3 months later revealed impaired ACTH, cortisol, and growth hormone (GH) responses, indicative of combined hypopituitarism. The patient also manifested symptoms of hypogonadism, and a hormonal workup suggested primary hypogonadism. At 12 months after discharge, GH and ACTH responses had recovered completely and partially, respectively. After another 3 months, basal ACTH and cortisol levels had been restored to the normal range and the patient discontinued hydrocortisone replacement without exacerbation of symptoms, although his hypogonadism persisted. The patient thus developed transient GH and ACTH deficiency that lasted for more than a year as well as persistent primary hypogonadism during intensive care for COVID-19. Certain prolonged symptoms of COVID-19 might be accounted for by such hormonal disturbance.

参考文献

1. Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA

(2019) Hypophysitis: an update on the novel forms, diag‐

nosis and management of disorders of pituitary inflamma‐

tion. Best Pract Res Clin Endocrinol Metab 33: 101371.

2. Chen H, Li Y, Zhang P, Wang Y (2020) A case report of

empty Sella syndrome secondary to Hantaan virus infec‐

tion and review of the literature. Medicine (Baltimore) 99:

e19734.

3. Ahn HJ, Chung JH, Kim DM, Yoon NR, Kim CM (2018)

Hemorrhagic fever with renal syndrome accompanied by

panhypopituitarism and central diabetes insipidus: a case

report. J Neurovirol 24: 382–387.

4. Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M,

et al. (2008) High risk of hypopituitarism in patients who

recovered from hemorrhagic fever with renal syndrome. J

Clin Endocrinol Metab 93: 2722–2728.

5. Tarvainen M, Makela S, Mustonen J, Jaatinen P (2016)

Autoimmune polyendocrinopathy and hypophysitis after

Puumala hantavirus infection. Endocrinol Diabetes Metab

Case Rep 2016: 16-0084.

6. Partanen T, Koivikko M, Leisti P, Salmela P, Paakko E, et

al. (2016) Long-term hormonal follow-up after human

Puumala hantavirus infection. Clin Endocrinol (Oxf) 84:

85–91.

7. Hautala T, Sironen T, Vapalahti O, Paakko E, Sarkioja T,

et al. (2002) Hypophyseal hemorrhage and panhypopitui‐

tarism during Puumala virus infection: magnetic reso‐

nance imaging and detection of viral antigen in the

hypophysis. Clin Infect Dis 35: 96–101.

8. Bhoelan S, Langerak T, Noack D, van Schinkel L,

van Nood E, et al. (2019) Hypopituitarism after ortho‐

hantavirus infection: what is currently known? Viruses 11:

340.

9. Hagg E, Astrom L, Steen L (1978) Persistent

hypothalamic-pituitary insufficiency following acute

meningoencephalitis. A report of two cases. Acta Med

Scand 203: 231–235.

10. Benabderrahim K (2020) Autoimmune hypophysitis and

viral infection in a pregnant woman: a challengeable case.

Pan Afr Med J 36: 28.

11. Vesely DL, Mastrandrea P, Samson C, Argyelan G,

Charvit S (2000) Post-herpes encephalitic anterior pitui‐

tary insufficiency with hypothermia and hypotension. Am

J Med Sci 320: 273–277.

12. Mulroney SE, McDonnell KJ, Pert CB, Ruff MR, Resch

Z, et al. (1998) HIV gp120 inhibits the somatotropic axis:

a possible GH-releasing hormone receptor mechanism for

the pathogenesis of AIDS wasting. Proc Natl Acad Sci U S

A 95: 1927–1932.

13. Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, et al.

(2005) Hypocortisolism in survivors of severe acute respi‐

ratory syndrome (SARS). Clin Endocrinol (Oxf) 63: 197–

202.

14. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S,

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

et al. (2020) Extrapulmonary manifestations of COVID-19.

Nat Med 26: 1017–1032.

Muller JA, Gross R, Conzelmann C, Kruger J, Merle U, et

al. (2021) SARS-CoV-2 infects and replicates in cells of

the human endocrine and exocrine pancreas. Nat Metab 3:

149–165.

Chong WH, Shkolnik B, Saha B, Beegle S (2021)

Subacute thyroiditis in the setting of coronavirus disease

2019. Am J Med Sci 361: 400–402.

San Juan MDJ, Florencio MQV, Joven MH (2020)

Subacute thyroiditis in a patient with coronavirus disease

2019. AACE Clin Case Rep 6: e361–e364.

Mizuno S, Inaba H, Kobayashi KI, Kubo K, Ito S, et al.

(2021) A case of postpartum thyroiditis following SARSCoV-2 infection. Endocr J 68: 371–374.

Dutta S, Sengupta P (2021) SARS-CoV-2 and male infer‐

tility: possible multifaceted pathology. Reprod Sci 28: 23–

26.

Selvaraj K, Ravichandran S, Krishnan S, Radhakrishnan

RK, Manickam N, et al. (2021) Testicular atrophy and

hypothalamic pathology in COVID-19: possibility of the

incidence of male infertility and HPG axis abnormalities.

Reprod Sci 28: 2735–2742.

Alvarez-Troncoso J, Zapatero Larrauri M, Montero Vega

MD, Gil Vallano R, Palmier Pelaez E, et al. (2020) Case

report: COVID-19 with bilateral adrenal hemorrhage. Am

J Trop Med Hyg 103: 1156–1157.

Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, et

al. (2020) Bilateral adrenal hemorrhage in coronavirus

disease 2019 patient: a case report. J Clin Endocrinol

Metab 105: dgaa487.

Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H,

Bakhsh A, et al. (2021) The impact of Covid-19 viral

infection on the hypothalamic-pituitary-adrenal axis.

Endocr Pract 27: 83–89.

Chan JL, Gregory KD, Smithson SS, Naqvi M, Mamelak

AN (2020) Pituitary apoplexy associated with acute

COVID-19 infection and pregnancy. Pituitary 23: 716–

720.

Ghosh R, Roy D, Roy D, Mandal A, Dutta A, et al. (2021)

A rare case of SARS-CoV-2 infection associated with

pituitary apoplexy without comorbidities. J Endocr Soc 5:

bvaa203.

Solorio-Pineda S, Almendarez-Sanchez CA, TafurGrandett AA, Ramos-Martinez GA, Huato-Reyes R, et al.

(2020) Pituitary macroadenoma apoplexy in a severe acute

respiratory syndrome-coronavirus-2-positive testing:

causal or casual? Surg Neurol Int 11: 304.

Urhan E, Karaca Z, Unuvar GK, Gundogan K,

Unluhizarci K (2022) Investigation of pituitary functions

after acute coronavirus disease 2019. Endocr J doi:

10.1507/endocrj.EJ21-0531. Online ahead of print.

Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R (2021)

Central adrenal insufficiency and diabetes insipidus as

1342

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

40.

Yoshimura et al.

potential endocrine manifestations of COVID-19 infec‐

tion: a case report. Pan Afr Med J 38: 222.

Gonen MS, De Bellis A, Durcan E, Bellastella G, Cirillo

P, et al. (2022) Assessment of neuroendocrine changes

and hypothalamo-pituitary autoimmunity in patients with

COVID-19. Horm Metab Res 54: 153–161.

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad

MH, et al. (2016) Hormonal replacement in hypopituitar‐

ism in adults: an Endocrine Society clinical practice

guideline. J Clin Endocrinol Metab 101: 3888–3921.

Tanaka T, Tachibana K, Shimatsu A, Katsumata N,

Tsushima T, et al. (2005) A nationwide attempt to

standardize growth hormone assays. Horm Res 64 Suppl

2: 6–11.

Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, et

al. (2012) Standardized centile curves and reference inter‐

vals of serum insulin-like growth factor-I (IGF-I) levels in

a normal Japanese population using the LMS method.

Endocr J 59: 771–780.

Gonen MS, De Bellis A, Durcan E, Bellastella G, Cirillo

P, et al. (2022) Assessment of neuroendocrine changes

and hypothalamo-pituitary autoimmunity in patients with

COVID-19. Horm Metab Res 54: 153–161.

Paul T, Ledderose S, Bartsch H, Sun N, Soliman S, et al.

(2022) Adrenal tropism of SARS-CoV-2 and adrenal find‐

ings in a post-mortem case series of patients with severe

fatal COVID-19. Nat Commun 13: 1589.

Boonen E, Vervenne H, Meersseman P, Andrew R,

Mortier L, et al. (2013) Reduced cortisol metabolism

during critical illness. N Engl J Med 368: 1477–1488.

Dahl R (2006) Systemic side effects of inhaled corticoste‐

roids in patients with asthma. Respir Med 100: 1307–

1317.

Corbett AH, Lim ML, Kashuba AD (2002) Kaletra

(lopinavir/ritonavir). Ann Pharmacother 36: 1193–1203.

Fintini D, Alba M, Schally AV, Bowers CY, Parlow AF,

et al. (2005) Effects of combined long-term treatment with

a growth hormone-releasing hormone analogue and a

growth hormone secretagogue in the growth hormonereleasing hormone knock out mouse. Neuroendocrinology

82: 198–207.

Mazziotti G, Giustina A (2013) Glucocorticoids and

the regulation of growth hormone secretion. Nat Rev

Endocrinol 9: 265–276.

Jost C, Krause R, Graninger W, Weber K (2009) Transient

41.

42.

43.

44.

45.

46.

47.

48.

49.

50.

51.

52.

53.

54.

hypopituitarism in a patient with nephropathia epidemica.

BMJ Case Rep 2009: bcr02.2009.1538.

Tan GH, Young WF Jr (1995) Transient hypopituitarism.

Endocr Pract 1: 320–322.

Jew K, Piziak V, Gilliland PF, Hurley DL (1984)

Meningoencephalitis complicated by pituitary insuffi‐

ciency and a spontaneously resolving suprasellar mass.

Neurosurgery 14: 567–569.

Kupari M, Pelkonen R, Valtonen V (1980) Postencephalitic hypothalamic-pituitary insufficiency. Acta

Endocrinol (Copenh) 94: 433–438.

Lazartigues E, Qadir MMF, Mauvais-Jarvis F (2020)

Endocrine significance of SARS-CoV-2’s reliance on

ACE2. Endocrinology 161: bqaa108.

Shibeeb S, Ahmad MN (2021) Thrombotic and hyper‐

coagulability complications of COVID-19: an update. J

Blood Med 12: 785–793.

Xu J, Qi L, Chi X, Yang J, Wei X, et al. (2006) Orchitis: a

complication of severe acute respiratory syndrome

(SARS). Biol Reprod 74: 410–416.

Creta M, Sagnelli C, Celentano G, Napolitano L, La

Rocca R, et al. (2021) SARS-CoV-2 infection affects the

lower urinary tract and male genital system: a systematic

review. J Med Virol 93: 3133–3142.

La Marca A, Busani S, Donno V, Guaraldi G, Ligabue G,

et al. (2020) Testicular pain as an unusual presentation of

COVID–19: a brief review of SARS-CoV-2 and the testis.

Reprod Biomed Online 41: 903–906.

Gacci M, Coppi M, Baldi E, Sebastianelli A, Zaccaro C,

et al. (2021) Semen impairment and occurrence of SARSCoV-2 virus in semen after recovery from COVID-19.

Hum Reprod 36: 1520–1529.

Salle V (2021) Coronavirus-induced autoimmunity. Clin

Immunol 226: 108694.

Ruggeri RM, Giuffrida G, Campenni A (2018) Autoim‐

mune endocrine diseases. Minerva Endocrinol 43: 305–

322.

Takahashi Y (2020) Mechanisms in endocrinology: auto‐

immune hypopituitarism: novel mechanistic insights. Eur

J Endocrinol 182: R59–R66.

Carfi A, Bernabei R, Landi F, Gemelli Against COVID-19

Post-Acute Care Study Group (2020) Persistent symptoms

in patients after acute COVID-19. JAMA 324: 603–605.

Higham CE, Johannsson G, Shalet SM (2016) Hypopitui‐

tarism. Lancet 388: 2403–2415.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る